Anne Zemella

639 total citations
30 papers, 458 citations indexed

About

Anne Zemella is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Ecology. According to data from OpenAlex, Anne Zemella has authored 30 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Ecology. Recurrent topics in Anne Zemella's work include RNA and protein synthesis mechanisms (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Anne Zemella is often cited by papers focused on RNA and protein synthesis mechanisms (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Anne Zemella collaborates with scholars based in Germany, United Kingdom and Switzerland. Anne Zemella's co-authors include Stefan Kubick, Lena Thoring, Christian Hoffmeister, Marlitt Stech, Srujan Kumar Dondapati, Doreen A. Wüstenhagen, Andrei Sonnabend, Mária Šamalíková, Christoph Stein and Viola Spahn and has published in prestigious journals such as Chemical Reviews, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anne Zemella

26 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Zemella Germany 9 374 104 73 66 55 30 458
Lena Thoring Germany 10 416 1.1× 123 1.2× 82 1.1× 75 1.1× 66 1.2× 16 500
In‐Seok Oh South Korea 11 424 1.1× 96 0.9× 89 1.2× 56 0.8× 90 1.6× 13 463
Kristen M. Wilding United States 8 349 0.9× 65 0.6× 54 0.7× 64 1.0× 42 0.8× 16 438
Emily E. Wrenbeck United States 6 374 1.0× 51 0.5× 37 0.5× 36 0.5× 94 1.7× 7 430
Justin R. Klesmith United States 11 403 1.1× 63 0.6× 34 0.5× 47 0.7× 115 2.1× 13 505
Shalom D. Goldberg United States 12 326 0.9× 75 0.7× 32 0.4× 21 0.3× 89 1.6× 15 454
Hanna Tegel Sweden 12 339 0.9× 85 0.8× 28 0.4× 43 0.7× 64 1.2× 28 462
Alexei Voloshin United States 9 578 1.5× 141 1.4× 98 1.3× 71 1.1× 90 1.6× 15 652
Brandon J. Sullivan United States 7 349 0.9× 69 0.7× 21 0.3× 34 0.5× 44 0.8× 9 419
Victoria Murray United States 6 287 0.8× 44 0.4× 22 0.3× 43 0.7× 44 0.8× 9 378

Countries citing papers authored by Anne Zemella

Since Specialization
Citations

This map shows the geographic impact of Anne Zemella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Zemella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Zemella more than expected).

Fields of papers citing papers by Anne Zemella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Zemella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Zemella. The network helps show where Anne Zemella may publish in the future.

Co-authorship network of co-authors of Anne Zemella

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Zemella. A scholar is included among the top collaborators of Anne Zemella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Zemella. Anne Zemella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casteleijn, Marco G., et al.. (2025). Beyond In Vivo, Pharmaceutical Molecule Production in Cell-Free Systems and the Use of Noncanonical Amino Acids Therein. Chemical Reviews. 125(3). 1303–1331. 3 indexed citations
2.
Dondapati, Srujan Kumar, et al.. (2024). A Cost-Effective Pichia pastoris Cell-Free System Driven by Glycolytic Intermediates Enables the Production of Complex Eukaryotic Proteins. Bioengineering. 11(1). 92–92. 1 indexed citations
3.
Zemella, Anne, et al.. (2024). Synthesis of biologically active Shiga toxins in cell-free systems. Scientific Reports. 14(1). 6043–6043. 2 indexed citations
4.
Zemella, Anne, Ariane Düx, Kevin Merkel, et al.. (2024). Vaccine-induced neutralizing antibodies bind to the H protein of a historical measles virus. International Journal of Medical Microbiology. 314. 151607–151607.
5.
Zemella, Anne, et al.. (2024). Solubilization of Oligomeric Cell-Free Synthesized Proteins Using SMA Copolymers. Methods in molecular biology. 2762. 293–308.
6.
Ewers, Helge, et al.. (2024). Fast In Vitro Synthesis and Direct Labeling of Nanobodies for Prototyping in Microscopy Applications. ACS Omega. 9(33). 35374–35383. 3 indexed citations
7.
Zemella, Anne, et al.. (2023). One to one comparison of cell-free synthesized erythropoietin conjugates modified with linear polyglycerol and polyethylene glycol. Scientific Reports. 13(1). 6394–6394. 3 indexed citations
8.
Dondapati, Srujan Kumar, et al.. (2023). Evaluation of the Ion Channel Assembly in a Eukaryotic Cell-Free System Focusing on Two-Pore Domain Potassium Channels K2P. International Journal of Molecular Sciences. 24(7). 6299–6299. 5 indexed citations
10.
Stech, Marlitt, et al.. (2023). Rapid One-Step Capturing of Native, Cell-Free Synthesized and Membrane-Embedded GLP-1R. International Journal of Molecular Sciences. 24(3). 2808–2808. 6 indexed citations
11.
Zemella, Anne, et al.. (2022). Cell-Free Systems Enable the Production of AB5 Toxins for Diagnostic Applications. Toxins. 14(4). 233–233. 15 indexed citations
12.
Stech, Marlitt, et al.. (2022). A CHO-Based Cell-Free Dual Fluorescence Reporter System for the Straightforward Assessment of Amber Suppression and scFv Functionality. Frontiers in Bioengineering and Biotechnology. 10. 873906–873906. 6 indexed citations
13.
Liers, Christiane, et al.. (2022). Cell-free production of the bifunctional glycoside hydrolase GH78 from Xylaria polymorpha. Enzyme and Microbial Technology. 161. 110110–110110. 4 indexed citations
14.
Dondapati, Srujan Kumar, et al.. (2022). The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins. Frontiers in Bioengineering and Biotechnology. 10. 896751–896751. 1 indexed citations
15.
Stech, Marlitt, et al.. (2021). Synthesis of Fluorescently Labeled Antibodies Using Non-Canonical Amino Acids in Eukaryotic Cell-Free Systems. Methods in molecular biology. 2305. 175–190. 6 indexed citations
16.
Dondapati, Srujan Kumar, Lena Thoring, Anne Zemella, et al.. (2020). Mammalian cell-free protein expression promotes the functional characterization of the tripartite non-hemolytic enterotoxin from Bacillus cereus. Scientific Reports. 10(1). 2887–2887. 17 indexed citations
17.
Dondapati, Srujan Kumar, Marlitt Stech, Anne Zemella, & Stefan Kubick. (2020). Cell-Free Protein Synthesis: A Promising Option for Future Drug Development. BioDrugs. 34(3). 327–348. 81 indexed citations
18.
Zemella, Anne, et al.. (2019). A Combined Cell-Free Protein Synthesis and Fluorescence-Based Approach to Investigate GPCR Binding Properties. Methods in molecular biology. 1947. 57–77. 10 indexed citations
19.
Zemella, Anne, Lena Thoring, Christian Hoffmeister, et al.. (2018). Cell-free protein synthesis as a novel tool for directed glycoengineering of active erythropoietin. Scientific Reports. 8(1). 8514–8514. 35 indexed citations
20.
Zemella, Anne, Solveig Großmann, Rita Sachse, et al.. (2017). Qualifying a eukaryotic cell-free system for fluorescence based GPCR analyses. Scientific Reports. 7(1). 3740–3740. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026